Havn Life (CSE: HAVN): The Future of Psychedelic Medicine HAVN Labs is building a psychedelic supply chain for clinical researchers Through research, extraction, formulation and delivery of psychedelics, we aspire to define and standardize the future of modern medicine
Investors - Havn Life (CSE: HAVN) HAVN Life (CSE: HAVN) is focused on the rapidly growing field of psychedelic medicine Get investors information here
About - Havn Life About Us OVERVIEW TEAM MARKET ROADMAP We believe in people and their potential We envision a world where everyone is operating at peak mental performance, free from the stresses and imbalances that hold us back MISSION Empowering human potential Using evidence-informed research, we are on a mission to unlock human performance and empower people to […]
HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co . . . Vancouver, BC – Havn Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it has secured a product listing agreement with Calgary Co-op for the Company’s line of natural health products, launched
HAVN Life Launches the Brain Evolve Series HAVN Life’s Brain Evolve Series includes a range of natural ingredients that are known to support trauma recovery and counteract the effects of brain degeneration Each formulation is designed to support inflammation reduction and restorative sleep, and promote increased energy and memory
Havn Life Sciences Enters Definitive Agreement to Acquire Strategic . . . Vancouver, BC – Havn Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has entered into a definitive agreement (the “ Definitive Agreement ”) to acquire (the “ Acquisition
HAVN Life Enters into Definitive Agreement to Acquire Spore Life . . . Vancouver, BC – Havn Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind, is pleased to announce it has entered into a definitive agreement (the “ Definitive Agreement ”) to acquire
HAVN LIFE SCIENCES Inc. Announces Cease Trade Order Vancouver, BC – HAVN Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “ Company ” or “ HAVN Life “), announces that on November 9, 2023, the British Columbia Securities Commission (the “BCSC”) has issued a general “failure to file” cease trade order pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions
HAVN Life To Begin Supplying its Naturally Derived Psilocybin Products . . . Vancouver, BC – Havn Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce its participation in Project Solace, launching in Canada this July A collaboration between Canadian non-profit TheraPsil
HAVN Life Enters into Agreement to Distribute its Line of Natural . . . Vancouver, BC – HAVN Life Sciences Inc (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce it has entered into an agreement (“ Agreement ”) with Sydney-based Woke Pharmaceuticals Pty Ltd